<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="42476" whole_study_id="24054" phs="001466" v="2" p="1" createDate="2021-06-15T10:19:08-05:00" completedByGPADate="2021-06-15T10:49:29-05:00" modDate="2022-01-25T16:16:28-05:00" maxParentChildStudyModDate="2022-01-25T16:16:28-05:00" handle="TOPMed_WGS_PharmHU" num_participants=""><StudyInfo accession="phs001466.v2.p1" parentAccession="phs001466.v2.p1"><BioProject id="PRJNA413114" entrez_id="413114" type="bp_admin_access"/><BioProject id="PRJNA413115" entrez_id="413115" type="bp_data_submission"/><StudyNameEntrez>NHLBI TOPMed: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>whole_genome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="EBOERWINKLE" aid="2" auth="eRA" login="EBOERWINKLE" fname="ERIC" mname="A" lname="BOERWINKLE" email="Eric.Boerwinkle@uth.tmc.edu"><Role allow_direct_access="true">PI</Role><Organization>UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON</Organization></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Camille" lname="Breaux" email="Camille.J.Breaux@uth.tmc.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The Trans-Omics for Precision Medicine (TOPMed) Acknowledgement Statement can be found at https://topmed.nhlbi.nih.gov/acknowledgements. In addition please include: &#8220;The TOPMed Whole Genome Sequencing Project: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU) is a collaboration between five medical institutions. Blood samples were collected at Baylor College of Medicine for sickle cell disease research studies using internal funding.  Samples were collected at Augusta University as part of the Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug) Follow-Up Observational Study II supported by the Medical College of Georgia Foundation Francis J. Tedesco Distinguished Chair held by Betty Pace, M.D. The work at Columbia University Medical Center was supported by a grant from the NIH to Columbia University from the Best Pharmaceutical for Children&#8217;s Act (3UL1RR024156-04S4) to Nancy S. Green, M.D.  Emory University School of Medicine blood sample collection was supported by NHLBI grant 1U01HL117721-01.  Funding for the Sickle Cell Clinical Research and Intervention Program (SCCRIP) at St Jude Children&#8217;s Research Hospital was through St. Jude Children&#8217;s Research Hospital and the American Lebanese Syrian Associated Charities (ALSAC).&#8221;</acknowledgement_statement><ic_specific_access_term>Three consent groups are available for this study: Health/Medical/Biomedical (HMB), Disease Specific (DS), and Disease Specific and related disorders (DS-RD). For HMB: Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.  For DS: Use of the data is limited to Sickle Cell Disease. For DS-RD: Use of the data is limited to Sickle Cell Disease and related disorders. </ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="2495" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2496" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease, RD)" name="DS-SCD-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Sickle Cell Disease and related disorders.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2497" CGType="cg_class_EA" title="Exchange Area" name="EA" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use by NHLBI WGS study investigators only.
There are three consent groups for this study: HMB, DS-SCD, and DS-SCD-RD.
1) For HMB: Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
2) For DS-SCD: Use of the data must be related to Sickle Cell Disease.
3) For DS-SCD-RD: Use of the data must be related to Sickle Cell Disease and related disorders.
</Use-Restriction></ConsentGroup><ConsentGroup uid="2918" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease)" name="DS-SCD" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Sickle Cell Disease.

</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="24054" whole_study_id="24054" phs="001466" v="1" p="1" createDate="2017-03-24T17:21:21-05:00" completedByGPADate="2017-04-03T13:27:42-05:00" modDate="2021-06-15T10:19:13-05:00" maxParentChildStudyModDate="2021-06-15T10:19:13-05:00" handle="TOPMed_WGS_PharmHU" num_participants=""><StudyInfo accession="phs001466.v1.p1" parentAccession="phs001466.v1.p1"><BioProject id="PRJNA413114" entrez_id="413114" type="bp_admin_access"/><BioProject id="PRJNA413115" entrez_id="413115" type="bp_data_submission"/><StudyNameEntrez>NHLBI TOPMed: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>whole_genome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="EBOERWINKLE" aid="2" auth="eRA" login="EBOERWINKLE" fname="ERIC" mname="A" lname="BOERWINKLE" email="Eric.Boerwinkle@uth.tmc.edu"><Role allow_direct_access="true">PI</Role><Organization>UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON</Organization></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Camille" lname="Breaux" email="Camille.J.Breaux@uth.tmc.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2000452640" aid="1" auth="cit" login="chensh2" fname="Shu Hui" mname="" lname="Chen" email="shuhui.chen@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The Trans-Omics for Precision Medicine (TOPMed) Acknowledgement Statement can be found at https://www.nhlbiwgs.org/acknowledgement. In addition please include: &#8220;The TOPMed Whole Genome Sequencing Project: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU) is a collaboration between five medical institutions. Blood samples were collected at Baylor College of Medicine for sickle cell disease research studies using internal funding.  Samples were collected at Augusta University as part of the Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug) Follow-Up Observational Study II supported by the Medical College of Georgia Foundation Francis J. Tedesco Distinguished Chair held by Betty Pace, M.D. The work at Columbia University Medical Center was supported by a grant from the NIH to Columbia University from the Best Pharmaceutical for Children&#8217;s Act (3UL1RR024156-04S4) to Nancy S. Green, M.D.  Emory University School of Medicine blood sample collection was supported by NHLBI grant 1U01HL117721-01.  Funding for the Sickle Cell Clinical Research and Intervention Program (SCCRIP) at St Jude Children&#8217;s Research Hospital was through St. Jude Children&#8217;s Research Hospital and the American Lebanese Syrian Associated Charities (ALSAC).&#8221;</acknowledgement_statement><ic_specific_access_term>Three consent groups are available for this study: Health/Medical/Biomedical (HMB), Disease Specific (DS), and Disease Specific and related disorders (DS-RD). For HMB: Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.  For DS: Use of the data is limited to Sickle Cell Disease. For DS-RD: Use of the data is limited to Sickle Cell Disease and related disorders. </ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="2495" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2496" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease, RD)" name="DS-SCD-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Sickle Cell Disease and related disorders.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2497" CGType="cg_class_EA" title="Exchange Area" name="EA" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use by NHLBI WGS study investigators only.
There are three consent groups for this study: HMB, DS-SCD, and DS-SCD-RD.
1) For HMB: Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
2) For DS-SCD: Use of the data must be related to Sickle Cell Disease.
3) For DS-SCD-RD: Use of the data must be related to Sickle Cell Disease and related disorders.
</Use-Restriction></ConsentGroup><ConsentGroup uid="2918" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease)" name="DS-SCD" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Sickle Cell Disease.

</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>